Kite Pharma

Kite Pharma, Inc.
Company typeSubsidiary
Nasdaq: KITE
IndustryBiopharmaceutical
Founded2009 (2009)
FounderArie Belldegrun and Joshua Kazam
FateAcquired by Gilead Sciences
Headquarters
Santa Monica
,
California
Key people
  • Christi Shaw (CEO)
  • Mert Aktar (Head of Corporate Development)
  • Warner Biddle (Global Head of Commercial)
ProductsCancer immunotherapy
Number of employees
2,000
ParentGilead Sciences
Websitewww.kitepharma.com
Footnotes / references
Key People, Founder

Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.